DEA’s Proposed Interim Rules Throw CBD Industry into Legal Jeopardy
August 30, 2020
Annual Growth in Average Cannabis Spending
September 8, 2020DEA’s Proposed Interim Rules Throw CBD Industry into Legal Jeopardy
August 30, 2020Annual Growth in Average Cannabis Spending
September 8, 2020
- On August 20, the DEA released its interim final rules (IFR) for hemp production.
- Rule changes include removing restrictions on importing and exporting hemp, and removing FDA-approved, CBD-based drugs from schedule 5 of the Controlled Substances Act (CSA).
- One key rule regarding CBD processing drew widespread criticism from industry stakeholders, who complain that it effectively criminalizes vital elements of the CBD production process.
- Under the IFR, essentially all CBD manufacturers fall under control of large amounts of CSA schedule I controlled substances.
- The DEA asserted that the policy stance has been in effect since passage of the 2018 Farm Bill, though the agency is extending a public comment period through October 20.
